COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 294: Articles 2931-2940  | Next

A Phase 2, randomized, double-blind, placebo-controlled multi-center trial sub-study for the clinical effects of paridiprubart treatment in hospitalized critically ill patients with COVID-19 ARDS
Gordon, B., Allum, F., Brooks, M., Rajakulendran, N., Rampakakis, E., Sampalis, J., EB05 Study Investigators
10.1101/2023.09.21.23295853 — Posted: 2023-09-27
Vaccine Effectiveness Against Long COVID in Children: A Report from the RECOVER EHR Cohort
Razzaghi, H., Forrest, C., Hirabayshi, K., Allen, A., Wu, Q., Rao, S., Bunnell, T., Chrischilles, E. A., Cowell, L. G., Cummins, M. R., Hanauer, D. A., Higginbotham, M. J., Horne, B., Horowitz, C. R., Jhaveri, R., Kim, S., Mishkin, A., Muszynski, J., Naggie, S., Pajor, N. M., Paranjape, A., Schwenk, H. T., Sills, M. R., Tedla, Y. G., Williams, D. A., Bailey, C.
10.1101/2023.09.27.23296100 — Posted: 2023-09-27
Intimate partner violence and its correlates in middle-aged and older adults during the COVID-19 pandemic: A multi-country secondary analysis
Chang, G., Tucker, J., Walker, K., Chu, C., Miall, N., Tan, R., Wu, D.
10.1101/2023.09.26.23296197 — Posted: 2023-09-27
Genomic evolution of SARS-CoV-2 variants of concern under in vitro neutralising selection pressure following two doses of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine
Basile, K., Agius, J. E., Fong, W., McPhie, K., Fennel, M., Ko, D., Hueston, L., Lam, C., Arnott, A., Chen, S. C.-A., Maddocks, S., O Sullivan, M. V. N., Dwyer, D., Sintchenko, V., Kok, J., Rockett, R. J., CIDMLS COVID-19 Study Group
10.1101/2023.09.24.558921 — Posted: 2023-09-27
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
Mühlemann, B., Wilks, S. H., Baracco, L., Bekliz, M., Carreno, J. M., Corman, V. M., Davis-Gardner, M. E., Dejnirattisai, W., Diamond, M., Doueck, D., Drosten, C., Eckerle, I., Edara, V. V., Ellis, M., Fouchier, R. A., Frieman, M., Godbole, S., Haagmans, B., Halfmann, P., Henry, A. R., Jones, T. C., Katzelnick, L., Kawaoka, Y., Kimpel, J., Krammer, F., Lai, L., Liu, C., Lusvarghi, S., Meyer, B., Mongkolsapaya, J., Montefiori, D., Mykytyn, A. Z., Netzl, A., Pollett, S., Rössler, A., Screaton, G., Shen, X., Sigal, A., Simon, V., Subramanian, R., Supasa, P., Suthar, M., Tureli, S., Wang, W., Weiss, C. D., Smith, D. J.
10.1101/2023.09.27.559689 — Posted: 2023-09-27
p38-MAPK is prerequisite for the synthesis of SARS-CoV-2 protein
Mittal, P., Khandelwal, N., Chander, Y., Verma, A., Kumar, R., Putatunda, C., Barua, S., Gulati, B. R., Kumar, N.
10.1101/2023.09.27.559660 — Posted: 2023-09-27
survInTime - Exploring surveillance methods and data analysis on Brazilian respiratory syndrome dataset and community mobility changes
Martins, Y. C., Francisco, R. d. S.
10.1101/2023.09.26.559599 — Posted: 2023-09-27
Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo
Kober, D. L., Caballero Van Dyke, M. C., Eitson, J. L. E. L., Rosenbaum, D., Schoggins, J. W.
10.1101/2023.09.26.559550 — Posted: 2023-09-27
SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variants
An, Y., Zhou, X., Tao, L., Xie, H., Li, D., Wang, R., Hu, H., Xu, Z., Dai, L., Xu, K., Gao, G. F.
10.1101/2023.09.26.559580 — Posted: 2023-09-27
Research ethics review during the COVID-19 pandemic An international study
Salamanca-Buentello, F., Katz, R., Silva, D. S., Upshur, R. E. G., Smith, M. J.
10.1101/2023.09.24.23296056 — Posted: 2023-09-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).